REXAHN PHARMACEUTICALS INC's ticker is REXN and the CUSIP is 761640309. A total of 15 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $485,000 | -18.4% | 233,302 | +11.5% | 0.00% | -100.0% |
| Q2 2020 | $594,000 | +77.8% | 209,301 | +12.7% | 0.00% | – |
| Q1 2020 | $334,000 | +18.0% | 185,762 | +25.2% | 0.00% | – |
| Q4 2019 | $283,000 | +26.3% | 148,333 | +36.0% | 0.00% | – |
| Q3 2019 | $224,000 | -49.7% | 109,104 | +26.5% | 0.00% | – |
| Q2 2019 | $445,000 | – | 86,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Royal Fund Management, LLC | 4 | $0 | 0.00% |
| American Portfolios Advisors | 8 | $15 | 0.00% |
| Renaissance Technologies | 148,333 | $283,000 | 0.00% |
| ROYAL BANK OF CANADA | 20 | $0 | 0.00% |
| VANGUARD GROUP INC | 55,584 | $106,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 49 | $0 | 0.00% |
| TCI Wealth Advisors, Inc. | 8 | $0 | 0.00% |
| UBS Group AG | 6,340 | $12,000 | 0.00% |
| NEXT Financial Group, Inc | 166 | $0 | 0.00% |
| Advisor Group, Inc. | 23 | $0 | 0.00% |